If the agency takes the panel's recommendations, clinicians could have the ability to prescribe six peptide therapies: BPC-157, MOTS-c, KPV, TB-500, Epitalon and Semax
The better move is to raise it with your clinician, who can ask about libido, arousal, and satisfaction to help differentiate medication effects from other causes and guide shared decisions about continuing or modifying treatment
Peptides such as GHK-Cu, GLOW Blend, Sermorelin, Tesamorelin, Ipamorelin, CJC-1295, and KLOW may be reviewed during consultation when appropriate
Additionally, semaglutide enhances insulin secretion when blood glucose rises, supporting better metabolic control
Scientific Session
Conversely, astrocytes also have beneficial roles during PD progression [21-22]